Look for these 6 nutrients in your diet to help ward off dementia and keep your brain sharp
Forgot your keys again? While many factors influence brain health, a nutritious diet that includes these nutrients can help slow the effects of time.
Pharmaceutical
The latest pharmaceutical industry news from MarketWatch.
Opinion These 7 momentum stocks ignited the market. Look out when they start to fall.
TheoTrade's Jeffrey Bierman on algorithmic trading: 'Nothing matters except what the algos can chase higher.' Beware the 'Magnificent Seven' stocks.
America’s first over-the-counter birth-control pill adds to expensive and sometimes unreliable options for women
‘We cannot take away access to abortion care without adequately offering pregnancy-prevention care,’ one health advocate said.
Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering
Biogen's all-cash deal is a rare-disease play.
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
Stock gains 5% after AstraZeneca's second-quarter results top analyst expectations.
Intel, Reata Pharma and Roku rally, and other movers
Roku's stock rallies after the streamer's results beat expectations.
Most Popular
More Pharmaceutical News
AbbVie shares jump as results beat expectations despite blockbuster Humira’s declining sales
Newer immunology drugs Skyrizi and Rinvoq boost sales in second quarter.
Bristol Myers stock takes a hit from earnings miss and lower outlook amid disappointing Revlimid sales
Shares of Bristol Myers Squibb Co. BMY shed 2.2% in premarket trading Thursday, after the drugmaker missed second-quarter earnings expectations and cut its full-year outlook, amid a more rapid than expected decline in sale...
Plan B morning-after pill maker reportedly seeking $4 billion sale
Private-equity backers are looking to sell Foundation Consumer Healthcare, the company which makes the Plan B emergency contraception pill, for about $4 billion, Bloomberg News reported Wednesday, citing people close to th...
How opioid abuse is afflicting older generations
Abuse of addictive painkillers is not just a problem among young people — the scourge increasingly is harming older adults.
Biogen to slash 1,000 jobs as it looks to save $700 million
Biotech giant's cost-cutting effort comes amid the launch of its Alzheimer's treatment, Leqembi.
AbbVie turns to newer immunology drugs as blockbuster Humira faces lower-cost competition
Investors look for signs that Skyrizi, Rinvoq can take the baton as Humira sales falter
Teva Pharmaceuticals and Alvotech expand biosimilars partnership
Teva Pharmaceuticals Industries Ltd. TEVA and Alvotech ALVO announced Monday that they are expanding their collaboration in the U.S. biosimilars market. Under the agreement, two new biosimilar candidates and line extension...
Pfizer says tornado greatly damaged warehouse; FDA downplays injection supply impact
Key production facility for injectable medicines remains closed while damage is assessed, pharmaceutical giant says.
Tornado damage at Pfizer facility threatens to make critical drug-supply shortages even worse, experts say
Natural disaster highlights need for longer-term policies to support generic availability, researchers say
These 13 S&P 500 stocks stand out for expected growth through 2025
Some big numbers have been baked into estimates for 2023. Looking out another two years can highlight opportunities in the stock market.
Cannabis pharma Mira Pharmaceuticals ups IPO size
Cannabis-focused Mira Pharmaceuticals Inc. increased the size of its initial public offering to 1.2 million shares and set the offering price at $7 a share, according to a filing late Friday. Mira earlier this month had sa...
Gilead ends late-stage trial of blood cancer treatment
Shares of Gilead Sciences Inc. GILD dropped nearly 2% in the extended session Friday after the pharma company said it has ended a late-stage trial of a treatment for a rare type of blood cancer after an analysis. “The heal...
Social Security, caregiving and prescription drug costs: Hot topics among older voters in the 2024 election
Voters aged 50 and older are 'extremely motivated' in the 2024 election, a poll found.
COVID pandemic is officially over in the U.S., excess-deaths data show
The COVID-19 pandemic is definitively over, according to two recent reports focused on the same metric.
RedHill Biopharma shares erase gains after company announces stock offering
The stock gained early Friday on news of fresh U.S. government funding for a treatment for radiation sickness, but the move was derailed by a stock offering.
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
Morgan Stanley on Friday lifted its forecast for weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
Johnson & Johnson’s stock jumps after earnings top estimates and company raises guidance
J&J's Medical-technologies business benefits as patients catch up on procedures they put off during the pandemic.
The stock rallies of the Dow’s earnings reporters are adding 120 points to the Dow’s price
The shares of the three Dow Jones Industrial Average components that reported earnings are a big reason the Dow is up Thursday while the broader stock market is down. Johnson & Johnson‘s stock rose 5.8% in morning trading ...
Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program
Johnson & Johnson JNJ has joined companies such as Merck & Co. Inc. MRK, Bristol Myers Squibb Co. BMY and other entities in suing the federal government over Medicare’s drug-price negotiation program. Merck was first with ...
Opioid use in people with dementia linked with 11 times higher risk of death within two weeks, new research shows
Nearly two-thirds of people with dementia using fentanyl patches died within six months, study finds
